Dr. Martens reports revenue decline amid strategic pivot to full price sales

UK-based footwear brand Dr. Martens has reported a decline in third quarter revenue as the company prioritises full price sales over promotional volume. For the 13 weeks ended December 28, 2025, group revenue fell 2.7 percent on a constant currency (CC) basis to 253 million pounds (346 million dollars).